Authors
Varchasvi Mudgal, Prashant Gaurav, Priyash Jain, Kartikay Chaturvedi
Published in
Indian journal of psychiatry. Volume 68. Issue 8. Pages 761-764. Epub Aug 20, 2026.
Abstract
Lumateperone is an approved treatment for bipolar depression with a low reported risk of treatment-emergent mania. However, real-world evidence remains limited.
We describe three adults with bipolar depression who developed manic symptoms within 10-14 days of initiating lumateperone 42 mg/day. Young Mania Rating Scale scores ranged from 26 to 29. Alternative causes were excluded, symptoms resolved after discontinuing lumateperone and optimizing mood stabilizers, and Naranjo scores (7-8) indicated a probable drug association.
Lumateperone may precipitate mania in susceptible individuals, highlighting the need for close monitoring during the early treatment period.
PMID:
42724943
Bibliographic data and abstract were imported from PubMed on 11 Sep 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 17
- Comments 0